
Magdalena Wygralak
GSK (NYSE:GSK) CEO Emma Walmsley said on Wednesday that her company is in discussions with the Trump administration on how to lower U.S. drug prices amid mounting pressure on pharmaceutical manufacturers to reduce their prices in line with those charged